Shuli Yang
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Obstetrics and Gynecology top 10%
- Uterine Myomas and Treatments
Papers in
-
- Gut microbiota and health 2
- Glycosylation and Glycoproteins Research 1
-
- Cancer-related molecular mechanisms research 3
- Co-authors
- Lihui Si (6 shared papers)Ruiqi Yang (2 shared papers)Shuang Liu (1 shared paper)Keshab R. Parajuli (1 shared paper)Zongbing You (1 shared paper)Leann Myers (1 shared paper)Yan Jia (4 shared papers)Shigang Ding (1 shared paper)
- Journals
- Frontiers in Endocrinology (2 papers)Cancer Letters (1 paper)Frontiers in Cellular and Infection Microbiology (1 paper)Frontiers in Microbiology (1 paper)Pancreas (1 paper)
- Partner nations
- ChinaUnited StatesEgypt
In The Last Decade
Shuli Yang
21 papers receiving 490 citations
Peers
Comparison fields: 5 of 79
- Cancer Research 97
- Obstetrics and Gynecology 42
- Pharmacology 43
- Oncology 111
- Immunology 82
Countries citing papers authored by Shuli Yang
This map shows the geographic impact of Shuli Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuli Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuli Yang more than expected).
Fields of papers citing papers by Shuli Yang
This network shows the impact of papers produced by Shuli Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuli Yang. The network helps show where Shuli Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Shuli Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 159 | |
| 2 | 2016 | 55 | |
| 3 | 2018 | 54 | |
| 4 | Kaempferol exerts anti-proliferative effects on human ovarian cancer cells by inducing apoptosis, G0/G1 cell cycle arrest and modulation of MEK/ERK and STAT3 pathways. | 2020 | 37 |
| 5 | 2023 | 25 | |
| 6 | 2014 | 25 | |
| 7 | 2011 | 21 | |
| 8 | 2020 | 17 | |
| 9 | 2023 | 17 | |
| 10 | 2019 | 16 | |
| 11 | MicroRNA-375 inhibits the growth, drug sensitivity and metastasis of human ovarian cancer cells by targeting PAX2. | 2020 | 12 |
| 12 | 2023 | 10 | |
| 13 | 2019 | 10 | |
| 14 | 2019 | 10 | |
| 15 | 2024 | 9 | |
| 16 | 2024 | 7 | |
| 17 | 2023 | 5 | |
| 18 | 2025 | 3 | |
| 19 | Using buffy coat for reverse transcriptase-polymerase chain reaction in the diagnosis of dengue virus infection: preliminary study. | 2000 | 3 |
| 20 | Molybdenum and esophageal cancer in china | 1981 | 3 |
About Shuli Yang
Shuli Yang is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Immunology and Surgery, having authored 21 papers that have together received 499 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (3 papers), Endometriosis Research and Treatment (2 papers), Gut microbiota and health (2 papers), Reproductive System and Pregnancy (2 papers), Click Chemistry and Applications (1 paper), Ferroptosis and cancer prognosis (1 paper), Glycosylation and Glycoproteins Research (1 paper) and Pregnancy-related medical research (1 paper). The work is most often cited by research in Cancer Research (97 citations), Obstetrics and Gynecology (42 citations), Pharmacology (43 citations), Oncology (111 citations) and Immunology (82 citations). Shuli Yang has collaborated with scholars based in China, United States and Egypt. Frequent co-authors include Lihui Si, Ruiqi Yang, Shuang Liu, Keshab R. Parajuli, Zongbing You, Leann Myers, Yan Jia, Shigang Ding, Shuai Ma and Xiaolin Wang. Their work appears in journals such as Frontiers in Endocrinology, Cancer Letters, Frontiers in Cellular and Infection Microbiology, Frontiers in Microbiology and Pancreas.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.